Antibe Provides April 2023 Corporate Update
Antibe Therapeutics Inc. , a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies to target inflammation, is pleased to provide a corporate... | April 11, 2023
Antibe Therapeutics Inc Singapore International Arbitration Centre Progress In Emerging Discovery Program Antibe Therapeutics Otenaproxesul Expands Chronic Pain Treatment
Source: marketscreener.com